SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-025192
Filing Date
2018-09-25
Accepted
2018-09-25 18:05:56
Documents
1
Period of Report
2018-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4187
  Complete submission text file 0000899243-18-025192.txt   5752
Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511
Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1650 TYSONS BOULEVARD SUITE 1700 MCLEAN VA 22102
Business Address
Milligan Peter J (Reporting) CIK: 0001531049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 181086512